
Guardant Health GH
$ 102.98
0.0%
Quarterly report 2025-Q2
added 07-30-2025
Guardant Health Operating Cycle 2011-2025 | GH
Annual Operating Cycle Guardant Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.1 | 60.2 | 79.1 | 73.7 | 64.5 | 160 | 221 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 221 | 49.1 | 101 |
Quarterly Operating Cycle Guardant Health
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 139 | 141 | - | 45 | 130 | 134 | - | 55.9 | 57.8 | 65.4 | - | 33.5 | 35.2 | 86.4 | - | 55.1 | 50.4 | 58.8 | - | 65.2 | 73.3 | 68.5 | - | 72 | 81.1 | 104 | - | 150 | 168 | 132 | - | 52.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 168 | 33.5 | 85.6 |
Operating Cycle of other stocks in the Diagnostics research industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
170 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
489 | - | -61.36 % | $ 2.46 M | ||
|
Burning Rock Biotech Limited
BNR
|
275 | $ 21.18 | - | $ 228 M | ||
|
Co-Diagnostics
CODX
|
405 | $ 0.24 | - | $ 7.04 M | ||
|
Castle Biosciences
CSTL
|
97.9 | $ 39.4 | - | $ 1.09 B | ||
|
Biocept
BIOC
|
134 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
164 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
150 | $ 230.32 | - | $ 168 B | ||
|
DarioHealth Corp.
DRIO
|
251 | $ 10.04 | - | $ 285 M | ||
|
BioNano Genomics
BNGO
|
329 | $ 1.52 | - | $ 1.93 M | ||
|
Exact Sciences Corporation
EXAS
|
269 | $ 101.57 | 0.03 % | $ 18.8 B | ||
|
DexCom
DXCM
|
204 | $ 67.57 | - | $ 26.1 B | ||
|
Enzo Biochem
ENZ
|
206 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 26.72 | - | $ 808 M | ||
|
Global Cord Blood Corporation
CO
|
202 | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
11.8 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
185 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
114 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
1.22 K | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 19.48 | - | $ 1.05 B | ||
|
Heska Corporation
HSKA
|
177 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
385 | $ 3.2 | - | $ 102 K | ||
|
HTG Molecular Diagnostics
HTGM
|
216 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
78 | $ 226.92 | - | $ 41.1 B | ||
|
Aspira Women's Health
AWH
|
73.8 | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
87.1 | $ 6.48 | - | $ 587 M | ||
|
ENDRA Life Sciences
NDRA
|
412 | $ 5.08 | 1.8 % | $ 2.73 M | ||
|
Neogen Corporation
NEOG
|
213 | $ 7.13 | -0.14 % | $ 1.55 B | ||
|
National Research Corporation
NRC
|
33 | $ 18.66 | - | $ 458 M | ||
|
Illumina
ILMN
|
198 | $ 134.95 | - | $ 21.5 B | ||
|
Charles River Laboratories International
CRL
|
67.7 | $ 203.66 | 0.25 % | $ 10.5 B | ||
|
Quest Diagnostics Incorporated
DGX
|
56.9 | $ 175.94 | - | $ 19.5 B | ||
|
Biodesix
BDSX
|
41.7 | $ 6.82 | - | $ 884 M | ||
|
Motus GI Holdings
MOTS
|
3.45 K | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
72.9 | $ 253.89 | -0.22 % | $ 21.3 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 182.84 | -0.46 % | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
135 | $ 688.48 | - | $ 56.8 B | ||
|
Lantheus Holdings
LNTH
|
116 | $ 66.71 | - | $ 4.62 B | ||
|
Mettler-Toledo International
MTD
|
63.7 | $ 1 420.1 | 0.21 % | $ 30.1 B | ||
|
Agilent Technologies
A
|
161 | $ 138.39 | - | $ 42.1 B | ||
|
Biomerica
BMRA
|
204 | $ 2.7 | - | $ 6.2 M | ||
|
Bioventus
BVS
|
267 | $ 7.46 | 1.08 % | $ 467 M | ||
|
NeoGenomics
NEO
|
103 | $ 12.28 | -0.16 % | $ 1.56 B | ||
|
Koninklijke Philips N.V.
PHG
|
89 | $ 27.11 | - | $ 20 B |